NCT02836522View on ClinicalTrials.gov

Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

CompletedOBSERVATIONAL
Enrollment

406

Participants

Timeline

Start Date

April 25, 2016

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Anal High-Grade Squamous Intraepithelial Lesions
Interventions
BEHAVIORAL

Assessment of Health-Related Quality

Demographic Questionnaire, ANCHOR HRSI, FACT-G, MDASI, Patient ECOG PS, PGIC

Trial Locations (4)

10021

Memorial Sloan - Kettering Cancer Center, New York

10031

City College of New York, New York

10065

New York Presbyterian Hospital-Weill Medical College of Cornell University, New York

60208

Northwestern University, Evanston

All Listed Sponsors
collaborator

The City College of New York

OTHER

collaborator

Northwestern University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT02836522 - Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL) | Biotech Hunter | Biotech Hunter